[Tamoxifen; wider indications, more frequent controls?].
Mourits
M J
MJ
van der Zee
A G
AG
Willemse
P H
PH
de Vries
E G
EG
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D006801:Humans; D009426:Netherlands; D010048:Ovarian Cysts / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D017697:Premenopause; D013629:Tamoxifen / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen